• About us
• Contact

Advertisement

Person › Details

Gary Phillips (Pharmaxis Ltd. (ASX: PXS))

Phillips, Gary (Pharmaxis 201505 CEO)

 

	Organisation	Pharmaxis Ltd. (ASX: PXS)
	Product	anti-inflammatory drug

Record changed: 2020-09-21

Advertisement

More documents for Gary Phillips

• [1] Boehringer Ingelheim. (9/7/20). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for Diabetic Retinopathy". Ingelheim & Sydney....
• [2] Boehringer Ingelheim. (12/18/19). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for NASH". Ingelheim & Sydney....
• [3] Arix Bioscience plc. (8/6/18). "Press Release: Arix Bioscience Announces First VIPE Investment". London....
• [4] Boehringer Ingelheim. (8/24/17). "Press Release: Boehringer Ingelheim Initiates Phase IIa Study of Compound Acquired from Pharmaxis in Debilitating Liver Disease NASH". Ingelheim & Sydney....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.